These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23983972)

  • 21. Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability.
    Singh SM; Haddad PM; Husain N; Heaney E; Tomenson B; Chaudhry IB
    Ther Adv Psychopharmacol; 2016 Jun; 6(3):162-71. PubMed ID: 27354904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study.
    Barbui C; Bertolini F; Bartoli F; Calandra C; Callegari C; Carrà G; D'Agostino A; Lucii C; Martinotti G; Mastromo D; Moretti D; Monzani E; Porcellana M; Prestia D; Ostuzzi G;
    Ther Adv Psychopharmacol; 2020; 10():2045125320978102. PubMed ID: 33489087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.
    Lin CH; Chen FC; Chan HY; Hsu CC
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):23-30. PubMed ID: 31481273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.
    Kim SW; Lee YH; Jang JE; Yoo T; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):80-6. PubMed ID: 23325306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-acting Injectable Antipsychotics in First-episode Schizophrenia.
    Jeong HG; Lee MS
    Clin Psychopharmacol Neurosci; 2013 Apr; 11(1):1-6. PubMed ID: 23678347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Acting Injectable Antipsychotics in Children and Adolescents.
    Lytle S; McVoy M; Sajatovic M
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):2-9. PubMed ID: 28112539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    J Affect Disord; 2021 Jan; 279():292-298. PubMed ID: 33096327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis.
    Prajapati AR; Wilson J; Song F; Maidment I
    Bipolar Disord; 2018 Dec; 20(8):687-696. PubMed ID: 30417552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.
    Gentile S
    Pharmacotherapy; 2013 Oct; 33(10):1087-106. PubMed ID: 23776129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports.
    Guinart D; Misawa F; Rubio JM; Pereira J; Sharma H; Schoretsanitis G; Kane JM; Correll CU
    J Clin Psychiatry; 2020 Nov; 82(1):. PubMed ID: 33238083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and emerging long-acting antipsychotics for the treatment of schizophrenia.
    de Filippis R; De Fazio P; Gaetano R; Steardo L; Cedro C; Bruno A; Zoccali RA; Muscatello MRA
    Expert Opin Drug Saf; 2021 Jul; 20(7):771-790. PubMed ID: 33775184
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.
    Kishimoto T; Nitta M; Borenstein M; Kane JM; Correll CU
    J Clin Psychiatry; 2013 Oct; 74(10):957-65. PubMed ID: 24229745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry.
    Kane JM; Kishimoto T; Correll CU
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S37-41. PubMed ID: 23849151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.
    Taylor D
    Br J Psychiatry Suppl; 2009 Nov; 52():S13-9. PubMed ID: 19880912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic long-acting injections in clinical practice: medication management and patient choice.
    Gray R; Spilling R; Burgess D; Newey T
    Br J Psychiatry Suppl; 2009 Nov; 52():S51-6. PubMed ID: 19880918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses.
    Geerts P; Martinez G; Schreiner A
    BMC Psychiatry; 2013 Feb; 13():58. PubMed ID: 23414331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.
    Kishimoto T; Robenzadeh A; Leucht C; Leucht S; Watanabe K; Mimura M; Borenstein M; Kane JM; Correll CU
    Schizophr Bull; 2014 Jan; 40(1):192-213. PubMed ID: 23256986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.